Identifying a Core Domain Set to Assess Psoriasis in Clinical Trials.

ABSTRACT: Importance:There is no consensus on which domains should be measured or which instruments should be used in clinical trials for psoriasis therapies. Objective:To achieve international consensus among psoriasis stakeholders on a core set of domains that should be measured in all psoriasis clinical trials. Design, Setting, and Participants:Literature review, pre-Delphi survey exercises, nominal group discussions, and audience voting at 4 stakeholder meetings were used to develop candidate domains for 2 rounds of a Delphi survey. Stakeholders were patients or advocates of patients with psoriasis and health care professionals (HCPs) with expertise in psoriasis, including physicians, scientists, advocacy organization representatives, and regulators. Delphi surveys were conducted electronically

SUBMITTER: Callis Duffin K 

PROVIDER: S-EPMC6233740 | biostudies-literature | 2018 Oct

REPOSITORIES: biostudies-literature